Who is sponsoring NCT04764123?

NCT04764123 is sponsored by Cardiovascular Research Society, Greece.

What drugs are being tested in NCT04764123?

Interventions in NCT04764123: AVNRT mapping.

What condition does NCT04764123 study?

NCT04764123 studies Tachycardia, Atrioventricular Nodal Reentry.

Is NCT04764123 still recruiting?

NCT04764123 is currently status unknown. Last updated 25 February 2021.

Last reviewed 2021-02-25 · How we verify

NCT04764123: AVNRTmap

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Typical and Atypical AVNRT High-resolution Mapping

Status unknown Last updated 25 February 2021

What this trial tests

trial testing AVNRT mapping in Tachycardia, Atrioventricular Nodal Reentry in 30 participants. Status unknown.

Timeline

1 June 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Cardiovascular Research Society, Greece
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 June 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023

Drugs / interventions tested

AVNRT mapping

Conditions studied

Tachycardia, Atrioventricular Nodal Reentry — all drugs for Tachycardia, Atrioventricular Nodal Reentry →

Sponsor

Cardiovascular Research Society, Greece

Who can join

Adults 16 to 75, any sex, with Tachycardia, Atrioventricular Nodal Reentry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed at : 1. Identifying the exact location of the circuit of typical and atypical AVNRT by applying high-resolution electroanatomic mapping. 2. Investigating the possibility that the recently described "ring tissues" participate in the AVNRT circuit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04764123 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardiovascular Research Society, Greece
Last refreshed: 25 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04764123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing